REUMUTH MARY (Chief Financial Officer) sold 2.4% of their position (1.71K shares) of KALA BIO, INC. on the open market
Open‑market sale worth $13.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2025ACC: 0001415889-25-001059
Officer· Chief Financial Officer
Since Jan 2019
+53.59K
Net shares
Net buyer
$13.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
55.30K acquired · 1.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.10K
Price / share
—
Trade value
—
% of position
16.8%
1/6/2025
60.19K→70.29K
Common Stock
Direct
Shares
−1.71K
Price / share
$7.63
Trade value
$13.02K
% of position
2.4%
1/6/2025
70.29K→68.58K
Total
Net shares
+8.39K
Net value
-$13.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2025 | A · Award | +10.10K | — | — | 16.8% | 60.19K | 70.29K |
| Common Stock Direct | 1/6/2025 | S · Sale | −1.71K | $7.63 | $13.02K | 2.4% | 70.29K | 68.58K |
| Total | +8.39K | -$13.02K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
45.20K shares
Shares
+45.20K
Strike price
7.53
Held after
45.20K
Exercisable
—
1/6/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock45.20K shares | 1/6/2025 | A · Award | +45.20K | 7.53 | — | 45.20K |